Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 190

The DOI matches its Crossref record.

Thalidomide as salvage therapy for chronic graft-versus-host disease

Parker, PM, Chao, N, Nademanee, A, O'Donnell, MR, Schmidt, GM, Snyder, DS, Stein, AS, Smith, EP, Molina, A, Stepan, DE · 1995 · Blood

Abstract

Thalidomide has been reported to be an effective agent for treatment of chronic graft-versus-host disease (CGVHD). To determine the efficacy of this agent in patients with refractory CGVHD a total of 80 patients who failed to respond to prednisone (PSE) or PSE and cyclosporine (CSA) were treated with thalidomide. Sixteen patients (20%) had a sustained response, 9 with a complete remission and 7 with a partial response. Twenty-nine patients (36%) had thalidomide discontinued because of side effects, which included sedation, constipation, neuritis, skin rash, and neutropenia. Side effects were reversible with drug discontinuation except for mild residual neuritis in one case. Rashes and neutropenia have not previously been reported as thalidomide side effects when used for CGVHD treatment. We conclude thalidomide is immunosuppressive and active in the treatment of CGVHD. A high incidence of reversible side effects limited dose intensity and reduced the number of patients who could benefit from treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood.v86.9.3604.bloodjournal8693604

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 190

Metadata

Authors
Parker, P., Chao, N., Nademanee, A., O'Donnell, M., Schmidt, G., Snyder, D., Stein, A., Smith, E., Molina, A., & Stepan, D.
Venue
Blood
Published
1995-11-01
Volume
86
Issue
9
Pages
3604-3609
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2395723318
Cited by
190
References
0
FWCI
3.70
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Thalidomide as salvage therapy for chronic graft-versus-host disease. https://app.cochat.ai/papers/10.1182/blood.v86.9.3604.bloodjournal8693604
The paper
Parker, P., Chao, N., Nademanee, A., O'Donnell, M., Schmidt, G., Snyder, D., Stein, A., Smith, E., Molina, A., & Stepan, D. (1995). Thalidomide as salvage therapy for chronic graft-versus-host disease. Blood. https://doi.org/10.1182/blood.v86.9.3604.bloodjournal8693604

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.